(1)
Toi, Y.; Kimura, Y.; Domeki, Y.; Kawana, S.; Aiba, T.; Ono, H.; Asou, M.; Tsurumi, K.; Suzuki, K.; Shimizu, H.; Sugisaka, J.; Saito, R.; Terayama, K.; Kawashima, Y.; Nakamura, A.; Yamanda, S.; Honda, Y.; Sugawara, S. Association of Low Body Surface Area With Dose Reduction and or Discontinuation of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis: a Pilot Study: BSA and Nintedanib Reduction Discontinuation. Sarcoidosis Vasc Diffuse Lung Dis 2019, 36 (1), 74-78. https://doi.org/10.36141/svdld.v36i1.7383.